Literature DB >> 34130956

Surgery and COVID-19: a rapid scoping review of the impact of the first wave of COVID-19 on surgical services.

Connor O'Rielly1, Joshua Ng-Kamstra2, Ania Kania-Richmond3, Joseph Dort4, Jonathan White5, Jill Robert6, Mary Brindle7, Khara Sauro8.   

Abstract

OBJECTIVES: To understand how surgical services have been reorganised during and following public health emergencies, particularly the first wave of the COVID-19 pandemic, and the consequences for patients, healthcare providers and healthcare systems.
DESIGN: A rapid scoping review.
SETTING: We searched the MEDLINE, Embase and grey literature sources for documents and press releases from governments and surgical organisations or associations. PARTICIPANTS: Studies examining surgical service delivery during public health emergencies including COVID-19, and the impact on patients, providers and healthcare systems were included. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcomes were strategies implemented for the reorganisation of surgical services. Secondary were the impacts of reorganisation and resuming surgical services, such as: adverse events (including morbidity and mortality), primary care and emergency department visits, length of hospital and ICU stay, and changes to surgical waitlists.
RESULTS: One hundred and thirty-two studies were included in this review; 111 described reorganisation of surgical services, 55 described the consequences of reorganising surgical services; and 6 reported actions taken to rebuild surgical capacity in public health emergencies. Reorganisations of surgical services were grouped under six domains: case selection/triage, personal protective equipment (PPE) regulations and practice, workforce composition and deployment, outpatient and inpatient patient care, resident and fellow education, and the hospital or clinical environment. Service reorganisations led to large reductions in non-urgent surgical volumes, increases in surgical wait times and impacted medical training (ie, reduced case involvement) and patient outcomes (eg, increases in pain). Strategies for rebuilding surgical capacity were scarce but focused on the availability of staff, PPE and patient readiness for surgery as key factors to consider before resuming services.
CONCLUSIONS: Reorganisation of surgical services in response to public health emergencies appears to be context dependent and has far-reaching consequences that must be better understood in order to optimise future health system responses to public health emergencies. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  health services administration & management; public health; surgery

Year:  2021        PMID: 34130956     DOI: 10.1136/bmjopen-2020-043966

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  4 in total

1.  Impact of COVID-19 on elective, emergency and oncological surgery during the first and the second wave in a tertiary university hospital : Have we learned the lessons?

Authors:  Lukas Gasteiger; Julia Abram; Sebastian Klein; Pia Tscholl; Tobias Hell; Gabriel Putzer; Berthold Moser; Michael Joannidis; Judith Martini
Journal:  Wien Klin Wochenschr       Date:  2022-05-24       Impact factor: 2.275

2.  Analyzing historical and future acute neurosurgical demand using an AI-enabled predictive dashboard.

Authors:  Anand S Pandit; Arif H B Jalal; Ahmed K Toma; Parashkev Nachev
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

3.  Delmicron and Flurona: Bracing for Surgical Impact.

Authors:  Christos Tsagkaris; Andreas S Papazoglou; Dimitrios V Moysidis; Anna Loudovikou; Dimitra Desse
Journal:  Disaster Med Public Health Prep       Date:  2022-05-04       Impact factor: 5.556

4.  Impact of the COVID-19 pandemic on the training of general surgery residents: Surgical training and the COVID-19 pandemic.

Authors:  Călin Popa; Diana Schlanger; Florin Zaharie; Nadim Al Hajjar
Journal:  Eur Surg       Date:  2022-09-09       Impact factor: 0.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.